These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 39113268)

  • 41. HnRNP A1 and A/B interaction with PABPN1 in oculopharyngeal muscular dystrophy.
    Fan X; Messaed C; Dion P; Laganiere J; Brais B; Karpati G; Rouleau GA
    Can J Neurol Sci; 2003 Aug; 30(3):244-51. PubMed ID: 12945950
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Two different PABPN1 expanded alleles in a Mexican population with oculopharyngeal muscular dystrophy arising from independent founder effects.
    Rivera D; Mejia-Lopez H; Pompa-Mera EN; Villanueva-Mendoza C; Nava-Castañeda A; Garnica-Hayashi L; Cuevas-Covarrubias S; Zenteno JC
    Br J Ophthalmol; 2008 Jul; 92(7):998-1002. PubMed ID: 18577654
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Muscle MRI in a large cohort of patients with oculopharyngeal muscular dystrophy.
    Alonso-Jimenez A; Kroon RHMJM; Alejaldre-Monforte A; Nuñez-Peralta C; Horlings CGC; van Engelen BGM; Olivé M; González L; Verges-Gil E; Paradas C; Márquez C; Garibaldi M; Gallano P; Rodriguez MJ; Gonzalez-Quereda L; Dominguez Gonzalez C; Vissing J; Fornander F; Eisum AV; García-Sobrino T; Pardo J; García-Figueiras R; Muelas N; Vilchez JJ; Kapetanovic S; Tasca G; Monforte M; Ricci E; Gomez MT; Bevilacqua JA; Diaz-Jara J; Zamorano II; Carlier RY; Laforet P; Pelayo-Negro A; Ramos-Fransi A; Martínez A; Marini-Bettolo C; Straub V; Gutiérrez G; Stojkovic T; Martín MA; Morís G; Fernández-Torrón R; Lopez De Munaín A; Cortes-Vicente E; Querol L; Rojas-García R; Illa I; Diaz-Manera J
    J Neurol Neurosurg Psychiatry; 2019 May; 90(5):576-585. PubMed ID: 30530568
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recovery of damaged skeletal muscle in mdx mice through low-intensity endurance exercise.
    Frinchi M; Macaluso F; Licciardi A; Perciavalle V; Coco M; Belluardo N; Morici G; Mudò G
    Int J Sports Med; 2014 Jan; 35(1):19-27. PubMed ID: 23868681
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Soluble expanded PABPN1 promotes cell death in oculopharyngeal muscular dystrophy.
    Messaed C; Dion PA; Abu-Baker A; Rochefort D; Laganiere J; Brais B; Rouleau GA
    Neurobiol Dis; 2007 Jun; 26(3):546-57. PubMed ID: 17418585
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oculopharyngeal muscular dystrophy (OPMD): analysis of the PABPN1 gene expansion sequence in 86 patients reveals 13 different expansion types and further evidence for unequal recombination as the mutational mechanism.
    Robinson DO; Hammans SR; Read SP; Sillibourne J
    Hum Genet; 2005 Mar; 116(4):267-71. PubMed ID: 15645184
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The small compound Icerguastat reduces muscle defects in oculopharyngeal muscular dystrophy through the PERK pathway of the unfolded protein response.
    Naït-Saïdi R; Chartier A; Abgueguen E; Guédat P; Simonelig M
    Open Biol; 2023 Apr; 13(4):230008. PubMed ID: 37042114
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oculopharyngeal muscular dystrophy: a late-onset polyalanine disease.
    Brais B
    Cytogenet Genome Res; 2003; 100(1-4):252-60. PubMed ID: 14526187
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanical Overloading Increases Maximal Force and Reduces Fragility in Hind Limb Skeletal Muscle from Mdx Mouse.
    Ferry A; Parlakian A; Joanne P; Fraysse B; Mgrditchian T; Roy P; Furling D; Butler-Browne G; Agbulut O
    Am J Pathol; 2015 Jul; 185(7):2012-24. PubMed ID: 26009153
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mitochondrial dysfunction reveals the role of mRNA poly(A) tail regulation in oculopharyngeal muscular dystrophy pathogenesis.
    Chartier A; Klein P; Pierson S; Barbezier N; Gidaro T; Casas F; Carberry S; Dowling P; Maynadier L; Bellec M; Oloko M; Jardel C; Moritz B; Dickson G; Mouly V; Ohlendieck K; Butler-Browne G; Trollet C; Simonelig M
    PLoS Genet; 2015 Mar; 11(3):e1005092. PubMed ID: 25816335
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Progress in understanding the pathogenesis of oculopharyngeal muscular dystrophy.
    Fan X; Rouleau GA
    Can J Neurol Sci; 2003 Feb; 30(1):8-14. PubMed ID: 12619777
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Progressive myopathy in an inducible mouse model of oculopharyngeal muscular dystrophy.
    Mankodi A; Wheeler TM; Shetty R; Salceies KM; Becher MW; Thornton CA
    Neurobiol Dis; 2012 Jan; 45(1):539-46. PubMed ID: 21964252
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Case of Oculopharyngeal Muscular Dystrophy Caused by a Novel PABPN1 c.34G > T (p.Gly12Trp) Point Mutation without Polyalanine Expansion.
    Takahashi Y; Morimoto N; Nada T; Morimoto M; Eura N; Minami N; Nishino I
    J Neuromuscul Dis; 2023; 10(3):459-463. PubMed ID: 36847015
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PABPN1-Dependent mRNA Processing Induces Muscle Wasting.
    Riaz M; Raz Y; van Putten M; Paniagua-Soriano G; Krom YD; Florea BI; Raz V
    PLoS Genet; 2016 May; 12(5):e1006031. PubMed ID: 27152426
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Muscle ultrasound is a sensitive biomarker in oculopharyngeal muscular dystrophy.
    Kroon RHMJM; Kalf JG; Meijers RL; de Swart BJM; Cameron IGM; Doorduin J; van Alfen N; van Engelen BGM; Horlings CGC
    Muscle Nerve; 2022 Oct; 66(4):453-461. PubMed ID: 35859342
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Value of insoluble PABPN1 accumulation in the diagnosis of oculopharyngeal muscular dystrophy.
    Galimberti V; Tironi R; Lerario A; Scali M; Del Bo R; Rodolico C; Brizzi T; Gibertini S; Maggi L; Mora M; Toscano A; Comi GP; Sciacco M; Moggio M; Peverelli L
    Eur J Neurol; 2020 Apr; 27(4):709-715. PubMed ID: 31769567
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mutation and haplotype analysis of oculopharyngeal muscular dystrophy in Thai patients.
    Pulkes T; Papsing C; Busabaratana M; Dejthevaporn C; Witoonpanich R
    J Clin Neurosci; 2011 May; 18(5):674-7. PubMed ID: 21316245
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevention of oculopharyngeal muscular dystrophy-associated aggregation of nuclear polyA-binding protein with a single-domain intracellular antibody.
    Verheesen P; de Kluijver A; van Koningsbruggen S; de Brij M; de Haard HJ; van Ommen GJ; van der Maarel SM; Verrips CT
    Hum Mol Genet; 2006 Jan; 15(1):105-11. PubMed ID: 16319127
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stuart has got the PoWeR! Skeletal muscle adaptations to a novel heavy progressive weighted wheel running exercise model in C57BL/6 mice.
    Koopmans PJ; Williams-Frey TD; Zwetsloot KA
    Exp Physiol; 2024 Feb; 109(2):271-282. PubMed ID: 37974360
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevention of oculopharyngeal muscular dystrophy by muscular expression of Llama single-chain intrabodies in vivo.
    Chartier A; Raz V; Sterrenburg E; Verrips CT; van der Maarel SM; Simonelig M
    Hum Mol Genet; 2009 May; 18(10):1849-59. PubMed ID: 19258344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.